Line Raaby

463 total citations
15 papers, 344 citations indexed

About

Line Raaby is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Line Raaby has authored 15 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Line Raaby's work include Psoriasis: Treatment and Pathogenesis (6 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Line Raaby is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Line Raaby collaborates with scholars based in Denmark, United States and Norway. Line Raaby's co-authors include Lars Iversen, Claus Johansen, Annette de Thurah, Ole Ahlehoff, Knud Kragballe, Kasper Fjellhaugen Hjuler, Christian Vestergaard, Hans Erik Bøtker, Mette Deleuran and Morten Bøttcher and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and British Journal of Dermatology.

In The Last Decade

Line Raaby

12 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Line Raaby Denmark 9 234 117 71 52 51 15 344
R.R.M.C. Keijsers Netherlands 10 291 1.2× 154 1.3× 56 0.8× 66 1.3× 56 1.1× 15 378
Emilie Hendrickx Belgium 8 324 1.4× 177 1.5× 50 0.7× 64 1.2× 67 1.3× 9 410
Monika Zabłotna Poland 12 228 1.0× 159 1.4× 43 0.6× 63 1.2× 65 1.3× 45 374
Caixia Li China 9 207 0.9× 82 0.7× 90 1.3× 32 0.6× 25 0.5× 21 377
S. Höxtermann Germany 11 161 0.7× 98 0.8× 83 1.2× 27 0.5× 92 1.8× 16 384
Yifan Hu China 10 139 0.6× 71 0.6× 67 0.9× 42 0.8× 24 0.5× 23 268
Gianluca Pagnanelli Italy 9 236 1.0× 165 1.4× 46 0.6× 55 1.1× 101 2.0× 21 337
Matilda Bylaitė Lithuania 9 81 0.3× 172 1.5× 62 0.9× 33 0.6× 70 1.4× 14 336
Julianty Angsana United States 8 187 0.8× 79 0.7× 49 0.7× 33 0.6× 19 0.4× 11 314
Hilda E. Ramón United States 8 538 2.3× 221 1.9× 89 1.3× 76 1.5× 103 2.0× 9 651

Countries citing papers authored by Line Raaby

Since Specialization
Citations

This map shows the geographic impact of Line Raaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Raaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Raaby more than expected).

Fields of papers citing papers by Line Raaby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Line Raaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Raaby. The network helps show where Line Raaby may publish in the future.

Co-authorship network of co-authors of Line Raaby

This figure shows the co-authorship network connecting the top 25 collaborators of Line Raaby. A scholar is included among the top collaborators of Line Raaby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Line Raaby. Line Raaby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Frydendahl, Amanda, Adam J. Widman, Jesper Nors, et al.. (2025). Whole‐genome sequencing of cell‐free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas. Molecular Oncology. 19(4). 984–993.
2.
Nielsen, Morten Muhlig, Lise M. Lindahl, Maria Gluud, et al.. (2024). RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides. Frontiers in Oncology. 14. 1421443–1421443.
3.
4.
Raaby, Line, Ole Ahlehoff, & Annette de Thurah. (2017). Psoriasis and cardiovascular events: updating the evidence. Archives of Dermatological Research. 309(3). 225–228. 50 indexed citations
5.
Raaby, Line, Cecilia Rosada, Pernille Ommen, et al.. (2017). Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment. Experimental Dermatology. 26(9). 804–810. 13 indexed citations
6.
Raaby, Line, Claus Zachariae, Monika Østensen, et al.. (2016). Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. Acta Dermato Venereologica. 97(4). 426–432. 41 indexed citations
7.
Olsen, Lene C., Pål Sætrom, Finn Drabløs, et al.. (2016). Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α. PLoS ONE. 11(12). e0167437–e0167437. 15 indexed citations
8.
Espinosa, Alexander, et al.. (2016). TRIM21 is important in the early phase of inflammation in the imiquimod‐induced psoriasis‐like skin inflammation mouse model. Experimental Dermatology. 26(8). 713–720. 16 indexed citations
9.
Hjuler, Kasper Fjellhaugen, Morten Bøttcher, Christian Vestergaard, et al.. (2015). Increased Prevalence of Coronary Artery Disease in Severe Psoriasis and Severe Atopic Dermatitis. The American Journal of Medicine. 128(12). 1325–1334.e2. 90 indexed citations
10.
Raaby, Line, et al.. (2015). Changes in mRNA expression precede changes in micro RNA expression in lesional psoriatic skin during treatment with adalimumab. British Journal of Dermatology. 173(2). 436–447. 32 indexed citations
11.
Mose, Maike, et al.. (2013). TNFα‐ and IL‐17A‐mediated S100A8 expression is regulated by p38 MAPK. Experimental Dermatology. 22(7). 476–481. 35 indexed citations
12.
13.
Gesser, Borbala, Mads Kirchheiner Rasmussen, Line Raaby, et al.. (2011). Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression. Inflammation Research. 60(7). 643–653. 35 indexed citations
14.
Raaby, Line, et al.. (2010). A characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis. Dermatology Reports. 2(2). e14–e14. 6 indexed citations
15.
Raaby, Line, et al.. (2009). Inter-observer variation of the Bandim TB-score. Scandinavian Journal of Infectious Diseases. 41(3). 220–223. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.R.M.C. Keijsers Breakdown of academic impact, for papers by Emilie Hendrickx Breakdown of academic impact, for papers by Monika Zabłotna Breakdown of academic impact, for papers by Caixia Li Breakdown of academic impact, for papers by S. Höxtermann Breakdown of academic impact, for papers by Yifan Hu Breakdown of academic impact, for papers by Gianluca Pagnanelli Breakdown of academic impact, for papers by Matilda Bylaitė Breakdown of academic impact, for papers by Julianty Angsana Breakdown of academic impact, for papers by Hilda E. Ramón
Rankless by CCL
2026